reslizumab 100 MG in 10 ML Injection

RxCUI: 1746893
RxNorm name: reslizumab 100 MG in 10 ML Injection
Display name: reslizumab 100 MG in 10 ML Injection
Full name: reslizumab 100 MG in 10 ML Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:46

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761033	Cinqair	reslizumab	351(a)	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CINQAIR	RESLIZUMAB	Teva Respiratory, LLC	053b9158-2a5b-48b9-bf47-5fa78a35ec33	2020-02-29	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1746893

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
053b9158-2a5b-48b9-bf47-5fa78a35ec33	reslizumab 100 MG in 10 ML Injection [PSN] · 10 ML reslizumab 10 MG/ML Injection [SCD] · reslizumab 100 MG per 10 ML Injection [SY]	3	14	These highlights do not include all the information needed to use CINQAIR safely and effectively. See full prescribing information for CINQAIR. CINQAIR ® (reslizumab) injection, for intravenous use Initial U.S. Approval: 2016	20200229